@misc{indiciaee8650d01c2da,
  title = {The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer},
  author = {Constantin, T. A. and Varela-Carver, A. and Greenland, K. K. and Serrano de Almeida, G. and Penfold, L. and Ang, S. and Ormrod, A. and Ainscow, E. K. and Bahl, A. K. and Carling, D. and Fuchter, M. J. and Ali, S. and Bevan, C. L.},
  year = {2022},
  doi = {10.1101/2022.06.29.497030},
  url = {https://www.biorxiv.org/content/10.1101/2022.06.29.497030v1},
  note = {Source identifier: 10.1101/2022.06.29.497030}
}